Frexalimab, CAS [[2515463-86-0]]

Produktübersicht

• Artikelname: Frexalimab, CAS [[2515463-86-0]]
• Artikelnummer: TGM-T77013
• Hersteller Artikelnummer: T77013
• Alternativnummer: TGM-T77013-1MG,TGM-T77013-5MG,TGM-T77013-10MG,TGM-T77013-25MG,TGM-T77013-50MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: INX-021 , INX021 , SAR-441344 , SAR441344

Produktbeschreibung

Frexalimab (SAR441344) is a second-generation humanized monoclonal antibody targeting CD40L. It blocks the CD40/CD40L signaling pathway to reduce inflammation and tissue damage, making it applicable for autoimmune diseases such as primary Sjögrens syndrome, systemic lupus erythematosus, and multiple sclerosis.

Produkteigenschaften

• Reinheit: 95.00%
• CAS Nummer: [2515463-86-0]
• Target-Kategorie: Immunology/Inflammation related